Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus

Rheumatology International

Volumn 21, Issue 6, 2002, Pages 227-233

  Manolova, I ^a   Dancheva, M ^a   Halacheva, K ^b  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b University Hospital Stara Zagora   (Bulgaria)

Author keywords

Antineutrophil cytoplasmic antibodies; IgG subclass distribution; Systemic lupus erythematosus

Indexed keywords

ANTIGEN; AUTOANTIBODY; DNA ANTIBODY; ENZYME ANTIBODY; GRANULOCYTE ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; LACTOFERRIN; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREACTIVITY; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LACTOFERRIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE PROTEINS; MIDDLE AGED; MYELOBLASTIN; PEROXIDASE; SERINE ENDOPEPTIDASES;

EID: 0036214125     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-002-0174-2     Document Type: Article

References (39)

1. Anti-neutrophil cytoplasmic antibodies in generalized autoimmune diseases
2. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis
3. Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis
4. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis
5. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus
6. Antilactoferrin antibody in systemic lupus erythematosus
7. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus
8. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus
9. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus
10. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease
11. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features
12. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: Prevalence, clinical associations and correlation with other autoantibodies
13. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: Prevalence, antigen specificity, and clinical associations
14. Immunoglobulin G subclass of human antinuclear antibodies
15. DNA antibody class, subclass and complement fixation in systemic lupus erythematosus with and without nephritis
16. IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases
17. Complement activation by antibodies to DNA in systemic lupus erythematosus measured by enzyme immunoassay
18. IgG subclasses of autoantibodies in systemic lupus erythematosus. Sjögren's syndrome, and drug-induced autoimmunity
19. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis, and clinically related disorders
20. IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis
21. Derivation of the SLEDAI: A disease activity index for lupus patients
22. Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes
23. The IgG subclass distribution of thyroid autoantibodies
24. Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis
25. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: Prevalence, titre, and IgG subclass
26. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: Prevalence, clinical correlates, and IgG subclass
27. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin
28. IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA)
29. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production
30. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
31. Mechanisms of the pathogenic autoimmune response in lupus
32. Cytokines in autoimmunity
33. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis
34. Cytokine production, serum levels and disease activity in systemic lupus erythematosus
35. Increased interferon-gamma (IFN-γ) IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
36. Anti-neutrophil cytoplasmic antibodies induce neutrophils to degranulate and produce oxygen radicals in vitro
37. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies
38. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): A FcγRII-dependent process
39. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: A predominant role for the IgG3 subclass of ANCA